Global 3D Bioprinting Research Report 2017: Short Term Forecast to 2021 & Overall Forecast to 2027 - Technologies, Markets, Forecasts - ResearchAndMarkets.com

DUBLIN--()--The "3D Bioprinting 2017-2027: Technologies, Markets, Forecasts" report has been added to ResearchAndMarkets.com's offering.

This report forecasts the overall 3D bioprinting market to 2027, with in depth discussion of key trends in the short term (2017 - 2021), and those expected in the long term (2022 - 2027). Market forecasts to 2027 are also provided for the 3D bioprinter market segmented by price point, and the 3D bioprinted tissue market segmented by tissue application.

This report profiles each technology and its subtypes, and provides key specifications, vendors, and SWOT analyses. This report also introduces and discusses emerging 3D bioprinting technologies of electrospinning, optical bioprinting, label-less magnetic levitation, and acoustic levitation. Technologies and considerations relevant to the 3D bioprinting process, such as software, bioink (including cell selection, growth factors, and scaffold materials), and post-printing maturation are also discussed.

Current and future applications for 3D bioprinting discussed in this report include:

  • Testing of cosmetics and other consumer goods
  • Drug screening
  • Personalised medicine
  • Regenerative medicine
  • Cell-based biosensors
  • Food and other animal products
  • Education
  • Academic research
  • Bionics

Regenerative Medicine

Special attention is paid to regenerative medicine in this report, as not only does it have the potential to be the largest application for 3D bioprinting in the future, but also one with the highest impact.

This report analyses how 3D bioprinting can be applied to regenerative medicine, and focuses on the following tissue types:

  • Bone and cartilage
  • Skin
  • Dental
  • Vasculature
  • Complex organs

Additionally, discussion of current progress in bringing 3D bioprinted tissues to the clinic is provided, as well future hurdles to be faced. A roadmap of 3D bioprinting in regenerative medicine to the year 2050 is provided.

Key Topics Covered:

1. EXECUTIVE SUMMARY

1.1. Overview

1.2. 3D Bioprinting Players

1.3. High Profile Partnerships

1.4. Successful Animal Tests

1.5. 3D Bioprinting Market Forecast 2017 - 2027

1.6. 3D Bioprinter Market Forecast 2017 - 2027

1.7. 3D Bioprinted Tissue Market Forecast 2017 - 2027

2. INTRODUCTION

2.1. Report Scope/3D Bioprinting Definition

2.2. 3D Bioprinting Process

2.3. 3D Cell Culture Advantages

2.4. 3D Bioprinting Advantages

2.5. Key Driver: Regenerative Medicine

2.6. Key Driver: Product Testing in Medicine

2.7. Key Driver: Product Testing in Consumer Products

2.8. Major Bioprinting Firsts

2.9. 3D Bioprinting in 2017

2.10. Key Trends: 3D Bioprinters

2.11. Key Trends: Bioprinted Tissues

2.12. Key Competing Technologies

2.13. Current Technical Challenges

2.14. Current Biological Challenges

2.15. Regulatory Hurdles

2.16. 3D Bioprinting SWOT Analysis

3. 3D BIOPRINTER TECHNOLOGIES

3.1. From 3D Printing to 3D Bioprinting

3.2. 3D Bioprinting Technologies

3.3. 3D Bioprinting Technology Comparison

3.4. Inkjet: Introduction

3.5. Extrusion: Introduction

3.6. Laser: Introduction

3.7. Microvalve: Introduction

3.8. Emerging Technology

3.9. Industry-wide Technical Challenges

3.10. The Ideal 3D Bioprinter

3.11. Future Technological Directions

4. RELATED TECHNOLOGIES

4.1. Related Technologies

4.2. 3D Bioprinting Software

4.3. Bioink Preparation

4.4. Cell Selection

4.5. Cell Selection: Regenerative Medicine

4.6. Growth Factors and Other Additives

4.7. Scaffold Materials

4.8. The Ideal Scaffold Material

4.9. Cell Spheroid Printing

4.10. Maturation

5. APPLICATIONS

5.1. Introduction

5.2. Testing of Cosmetics and Other Consumer Goods

5.3. Drug Screening

5.4. Drug Screening: Benefits of 3D Bioprinting

5.5. Personalised Medicine

5.6. Regenerative Medicine

5.7. Cell-Based Biosensors

5.8. Food and Other Animal Products

5.9. Education

5.10. Academic Research

5.11. Bionics

6. MARKETS AND FORECASTS

6.1. Introduction

6.2. Growing 3D Bioprinting Market

6.3. Market Barriers

6.4. Key Losers

6.5. Forecasts

6.6. Overall 3D Bioprinting Market Forecast 2017 - 2017

6.7. 3D Bioprinting Value Chain

6.8. 3D Bioprinter Manufacturers

6.9. 3D Bioprinter Market Forecast 2017 - 2027

6.10. 3D Bioprinting Service Bureaus

6.11. 3D Bioprinted Tissue Forecast 2017 - 2027

7. REGENERATIVE MEDICINE

7.1. Introduction

7.2. Regulatory Hurdles

7.3. Regenerative Medicine Advanced Therapy Designation

7.4. Ethics

7.5. Scams and Schemes

7.6. From Lab to Clinic

7.7. 3D Bioprinting Roadmap to 2050

8. APPENDIX

Companies Mentioned

  • 3D Bioprinting Solutions/Vivax Bio
  • 3Dynamic Systems Ltd
  • Aether Inc.
  • Aspect Biosystems
  • BioDan Group
  • Biobots
  • Cellenion SASU
  • Cellink
  • Digilab Inc.
  • GeSIM
  • MicroFab
  • Microdrop Technologies GmbH
  • Organovo Holdings, Inc.
  • PeptiGelDesign Ltd
  • Poietis
  • Regemat 3D
  • SE3D
  • Sichuan Revotek Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/932prw/global_3d?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: 3D Printing, Biomaterials

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: 3D Printing, Biomaterials